Historical Valuation
PATEO (02889) is now in the Overvalued zone, suggesting that its current forward PS ratio of 6.62 is considered Overvalued compared with the five-year average of -112.85. The fair price of PATEO (02889) is between 12.42 to 169.81 according to relative valuation methord. Compared to the current price of 234.80 USD , PATEO is Overvalued By 38.27%.
Relative Value
Fair Zone
12.42-169.81
Current Price：234.80
38.27%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
PATEO (02889) has a current Price-to-Book (P/B) ratio of 19.68. Compared to its 3-year average P/B ratio of 16.96 , the current P/B ratio is approximately 16.03% higher. Relative to its 5-year average P/B ratio of 16.96, the current P/B ratio is about 16.03% higher. PATEO (02889) has a Forward Free Cash Flow (FCF) yield of approximately -1.00%. Compared to its 3-year average FCF yield of -1.57%, the current FCF yield is approximately -36.31% lower. Relative to its 5-year average FCF yield of -1.57% , the current FCF yield is about -36.31% lower.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of 02889 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 02889 in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is 02889 currently overvalued or undervalued?
PATEO (02889) is now in the Overvalued zone, suggesting that its current forward PS ratio of 6.62 is considered Overvalued compared with the five-year average of -112.85. The fair price of PATEO (02889) is between 12.42 to 169.81 according to relative valuation methord. Compared to the current price of 234.80 USD , PATEO is Overvalued By 38.27% .
What is PATEO (02889) fair value?
02889's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of PATEO (02889) is between 12.42 to 169.81 according to relative valuation methord.
How does 02889's valuation metrics compare to the industry average?
The average P/S ratio for 02889's competitors is , providing a benchmark for relative valuation. PATEO Corp (02889) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for PATEO (02889) as of Jan 16 2026?
As of Jan 16 2026, PATEO (02889) has a P/B ratio of 19.68. This indicates that the market values 02889 at 19.68 times its book value.
What is the current FCF Yield for PATEO (02889) as of Jan 16 2026?
As of Jan 16 2026, PATEO (02889) has a FCF Yield of -1.00%. This means that for every dollar of PATEO’s market capitalization, the company generates -1.00 cents in free cash flow.
What is the current Forward P/E ratio for PATEO (02889) as of Jan 16 2026?
As of Jan 16 2026, PATEO (02889) has a Forward P/E ratio of -276.55. This means the market is willing to pay $-276.55 for every dollar of PATEO’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for PATEO (02889) as of Jan 16 2026?
As of Jan 16 2026, PATEO (02889) has a Forward P/S ratio of 6.62. This means the market is valuing 02889 at $6.62 for every dollar of expected revenue over the next 12 months.